Benicar Injury MDL $300 Million Settlement
Benicar Injury Lawsuits. Benicar (olmesartan) is part of a class of drugs called angiotensin receptor blockers (ARBs) and is approved to treat hypertension. The drug works by relaxing blood vessels so blood may flow more easily. Olmesartan is the active ingredient in the brand-name drug Benicar and is manufactured by … [Read more...] about Benicar Injury MDL $300 Million Settlement
Lawsuit Alleges Benicar HCT Makers Failed to Warn about Risk of Intestinal Side Effects
Daiichi Sankyo and Forest Laboratories are facing a new lawsuit alleging the companies failed to warn about the risk of gastrointestinal injuries with Benicar HCT, a high blood pressure medication. The plaintiff began taking the drug in April 2006, and alleges that it caused her to suffer gastrointestinal injuries and kidney failure. … [Read more...] about Lawsuit Alleges Benicar HCT Makers Failed to Warn about Risk of Intestinal Side Effects
Updated Label for Hypertension Drug Olmesartan
Label Updates for Hypertension Drug Olmesartan. In a Drug Safety Communication issued Tuesday, the U.S. Food and Drug Administration (FDA) said that upon completing its safety review of the blood pressure medication olmesartan it did not find conclusive evidence of increased cardiovascular risks in diabetic patients. In … [Read more...] about Updated Label for Hypertension Drug Olmesartan
